Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
about
Current and emerging biomarkers of cell death in human disease.The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver DiseaseCell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracyClinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis.Biomarker method validation in anticancer drug developmentMethod validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAP.Cellular and molecular mechanisms of liver injury.Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyCytokeratin 18 in plasma of patients with gastrointestinal adenocarcinoma as a biomarker of tumour response.Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.Cytokeratin-18 in Diagnosis of HCC in Patients with Liver CirrhosisLoss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin.The Clinical Significance of Serum Apoptotic Cytokeratin 18 Neoepitope M30 (CK-18 M30) and Matrix Metalloproteinase 2 (MMP-2) Levels in Chronic Hepatitis B Patients with Cirrhosis.Elevated serum levels of cell death circulating biomarkers, M30 and M65, in patients with β-thalassemia major.Cytokeratin 18-based cell death markers indicate severity of liver disease and prognosis of cirrhotic patients.
P2860
Q27690667-A1A53427-3304-458B-A84E-D91571501505Q28550881-CCF27C6C-1A80-4A23-A05A-9B412E5BC8FBQ33714356-308DE4C0-7BA9-4BB9-8FA6-20FCA36F37BEQ35653461-68C2E344-7CD2-4E91-80E6-3EBFBC3D7340Q36484621-466279A9-0BF5-4E7A-BF5B-820113FB711EQ36611534-F0C1F403-BF9A-40D8-B837-E9420A4F11D3Q36908855-0196C44D-EC8C-4D8B-9D96-BCA5115A4899Q37278502-AC777C11-4CE9-4EDE-90B8-679C05CD13FAQ37287486-BEF9D997-AB2A-4B68-B8DC-30A79BC23D57Q38725581-5FB20F48-59FD-4C56-929E-05521EFA4116Q39096520-2EC1BD1E-ED09-4A77-948F-2CB5A30E4671Q40473727-0EA3089B-9232-4633-B38E-EA2B40AE8B76Q42247927-5962F9C9-8B84-4117-9167-9E39A6EA063EQ43721625-B3E54516-4F01-4B39-9197-ABEBC4645D84Q54634837-F4877540-5626-46B9-BBA9-B5BD3B5B7CAB
P2860
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@en
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@nl
type
label
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@en
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@nl
prefLabel
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@en
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@nl
P2093
P2860
P1476
Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.
@en
P2093
Herrmann E
Kronenberger B
Sarrazin C
P2860
P304
P356
10.1111/J.1365-2893.2005.00594.X
P577
2005-05-01T00:00:00Z